Spot it sooner: a clinician's guide to early skin cancer detection. With melanoma, basal cell carcinoma, and squamous cell carcinoma on the rise, early diagnosis is key to curative outcomes. A new Medscape guide outlines five actionable strategies — from consistently applying the ABCDE rule to leveraging teledermatology — to help clinicians catch suspicious lesions before they progress.
Skin cancers — including melanoma, basal cell carcinoma (BCC), and squamous cell carcinoma (SCC) — are becoming increasingly common, and early detection dramatically improves the odds of curative treatment. A new Medscape guide outlines five practical strategies clinicians can integrate into routine practice to identify suspicious lesions sooner.
The framework starts with consistently applying the ABCDE rule (Asymmetry, Border, Color, Diameter, Evolution) — with "Evolution" flagged as especially critical, since any new, growing, bleeding, or changing lesion warrants prompt evaluation. Clinicians are also urged to screen high-risk patients more vigilantly, including those with fair skin, atypical nevi, immunosuppression, or a history of sun exposure. Documenting lesion progression with standardized photos and measurements over time is highlighted as a key tool for catching changes that might be missed in a single visit.
When in doubt, the guide stresses maintaining a low threshold for biopsy or referral — uncertain lesions shouldn't be watched for months. Finally, teledermatology is endorsed as a valuable triage tool, especially in areas with limited specialist access, though it can't replace in-person evaluation when suspicion is high.
Key Takeaways:
Why it matters: Most skin cancers are highly treatable when caught early, yet delays in diagnosis remain common. These five strategies give clinicians — especially those outside dermatology — a clear, systematic approach to closing that gap.
